How did the Coronavirus influence research? – New Episode of BIH-Podcast with John Ioannidis
During the Corona pandemic, half a million researchers from more than 170 different fields published articles about the virus or the COVID-19 disease. In the 32nd episode of the BIH-Podcast „Turning research into health“, John Ioannidis, famous meta-researcher from Stanford and Berlin, reflects about research integrity, transparency and sustainability of research results published in preprints, peer reviewed papers or social media.
During the Corona pandemic, half a million researchers from more than 170 different fields published articles about the virus or the COVID-19 disease. Many of them were not really virus-experts, even automobile researchers published about Corona. In the new episode of the BIH-podcast, John Ioannidis, famous meta-researcher from Stanford and Berlin, reflects about research integrity, transparency and sustainability of research results published in preprints, peer reviewed papers or social media.
His resume is clear: Not all results were fantastic and led to a new vaccine, but it was an exciting experiment for Science and the learning experience was tremendous! And he is still convinced: Science is the best thing that has happened to humans.
John Ioannidis is a professor of medicine at the Stanford Prevention Centre, professor of epidemiology and population health, of statistics and biomedical data science. He is also the director of METRICS at the Institute of Meta-Research at Stanford University. In 2019, John Ioannidis founded METRIC B, the Institute of Meta-Research at the Berlin Institute of Health @ Charité (BIH) in Berlin.
The Berlin Institute of Health at Charité
The mission of the Berlin Institute of Health (BIH) is medical translation: transferring biomedical research findings into novel approaches to personalized prediction, prevention, diagnostics and therapy and, conversely, using clinical observations to develop new research ideas. The aim is to deliver relevant medical benefits to patients and the population at large. The BIH is also committed to establishing a comprehensive translational ecosystem as translational research unit at Charité – one that places emphasis on a system-wide understanding of health and disease and that promotes change in the biomedical research culture. The BIH was founded in 2013 and is funded 90 percent by the Federal Ministry of Education and Research (BMBF) and 10 percent by the State of Berlin. The two founding institutions, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), were independent member entities within the BIH until 2020. As of 2021, the BIH has been integrated into Charité as its third pillar, the so-called translational research unit; the MDC is privileged partner of the BIH.
(Deutsch) Weitere Informationen: